ABSK141-Recommended Dose for Expansion (RDE) Clinical Trials

1 actively recruiting trial

Also known as: ABSK141, investigational drug

Pipeline

Phase 1/2: 1

Top Sponsors

Abbisko Therapeutics Co, Ltd1

Indications

Solid Tumors, Adult1
Cancer1

Other1 trial

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.